[1] Howell RW.Radiation spectra for Auger-electron emitting radionuclides:report No.2 of AAPM nuclear medicine task group No.6[J].Med Phys, 1992, 19:1372-1382.
[2] Stepanek J, Larsson B, Weinreich R.Auger electron spectra of radionuclides for therapy and diagnostics[J].Acta Oncol, 1996, 35:863-868.
[3] Sastry KSR.Biological effects of Auger emitter iodine-125[J].Med Phys, 1992, 19:1361-1370.
[4] Narra V R, Howell RW, Harapanhalli RS, et al.Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labled compounds in mouse tests:implications for radiopharmaceutical design[J].J Nucl Med, 1992, 33:2196-2201.
[5] Faraggi M, Gardin I, Mmoretti JL, et al.Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of Tc-99 m, I-123, In-111, Ga-67 and Tl-201[J].Eur J Nucl Med, 1998, 25:205-214.
[6] Hartman T, Lundqvist H, Westlin JE, et al.Radiation doses to the cell nucleus in single cells and cells in micrometastases in targed therapy with 131-I labeled ligands or antibodies[J].Int J Radiat Oncol Biol Phys, 2000, 46(4):1025-1036.
[7] Spinelli F, Sare R, Milella M, et al.Technotium-99m hexamethylpropylene axnine oxine leucocyte scintigraphy in the differential diagnosis of cerebral abscesses[J].Eur J Nucl Med, 2000, 27(1):46-49.
[8] Garcferndez R, Lwasaki I, Acosta F, et al.Scintigraphy with erythrocytes labelled in vitro with 99Tcm compared with 111In-octreptide in the detection of carotid glomus[J].Rev Invest Clin, 2000, 52(1):25-30.
[9] Narra V R, Sastry KRS, Goddu SM, et al.Relative biological effectiveness of Tc-99m radio-pharmaceuticals[J].Med Phys, 1994, 21:1921-1926.
[10] de Labriolle-Vayler C, Colas-Linhart N, Sala-Trepat M, et al.Biological consequence of the heterogeneous irradiation of lymphocytes during technetium-99m hexamethylpropylene amine oxime white blood cells labeling[J].Eur J Nucl Med, 1998, 25:1423-1428.
[11] Marjorie S, Nicole C, Colas-Linhart, et al.Heteroge-neous distribution of technetium-99m-labeled micro-spheres in rat lungs:microautoradiographic evidence and dosimetric consequences[J].J Nucl Med, 1997, 38:650-654.
[12] Puncher MRB, Blower PJ.Fronzen section microau-toradiography in the study of radionuclide targeting:application to indium-111-oxime-labled leucocytes[J].J Nucl Med, 1995, 36:499-505.
[13] Gardin I, Faraggi M, Huc E, et al.Modelling of the relationship between cell dimensions and mean dose delivered to the cell nucleus:application to five radionuclides used in nuclear medicine[J].Phys Med Biol, 1995, 40:1001-1014.
[14] Gardin I, Colas-Linhart N, Petiet A, et al.dosimetryat the cellular level of kupffer cells after technetium-99m-sulphur colloid injection[J].J Nucl Med, 1992, 33:380-384.
[15] Ernst M, Freed M E, Zametkin AJ.Health hazards of radiation exposure in the context of brain imaging research:special consideration for children[J].J Nucl Med, 1998, 39:689-698.